Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

10x Genomics Pays $350 Million to Acquire ReadCoor, a Spatial-Omics Company

publication date: Oct 6, 2020

10x Genomics acquired ReadCoor, a Boston developer of In Situ technologies, for $350 million. ReadCoor's technology measures large numbers of molecules directly in tissue while preserving the precise location of the molecules in the tissue, the growing field of spatial-omics. 10x provides scientific researchers with products to analyze biologic systems at a single cell level. Decheng Capital of Shanghai and Silicon Valley led ReadCoor's $23 million Series A financing and $27 million Series B round. More details....

Stock Symbol: (NSDQ: TXG) 

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital